Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Brawn Biotech Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹20.80 |
|---|---|
| Day's Range | ₹20.80 - ₹20.80 |
| Open | ₹20.80 |
| 52 Week Range | ₹15.70 - ₹24.37 |
| Volume | 105 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.02 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -0.46 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 1.66 |
| PAT Margin (%) | -12.92 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -42.59 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 38.45 | 164.95 |
| Expenses | N/A | N/A |
| PBT | -4.32 | -15.44 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -4.32 | -15.44 |
About Brawn Biotech Ltd.
| Founded | 1985 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Adani Enterprises Ltd. | 3,12,933.62 | 2,504.25 | 1,753.00 - 1,753.00 |
| Premier Energies Ltd. | 46,160.06 | 1,032.00 | 660.00 - 660.00 |
| Aditya Infotech Ltd. | 27,373.92 | 2,429.65 | 0.00 - 0.00 |
| Aegis Logistics Ltd. | 24,594.57 | 719.00 | 576.10 - 576.10 |
| Redington Ltd. | 16,878.51 | 222.20 | 191.31 - 191.31 |
| Honasa Consumer Ltd. | 11,093.48 | 340.00 | 237.00 - 237.00 |
| Lloyds Enterprises Ltd. | 10,441.62 | 69.37 | 40.69 - 40.69 |
| MMTC Ltd. | 9,709.50 | 65.55 | 50.10 - 50.10 |
| Cello World Ltd. | 9,212.01 | 420.25 | 382.55 - 382.55 |
| Jeena Sikho Lifecare Ltd. | 8,389.06 | 689.10 | 376.00 - 376.00 |
No Records Found
Latest News
Posted on May 4th
Godawari Power And Ispat informs about demise of member of promoter group
Posted on May 4th
Govt reports 8.7% growth in GST collection for April
Posted on May 2nd
Value 360 Communications coming with IPO to raise up to Rs 41.69 crore
Posted on Apr 30th
Currency futures for May expiry trade weaker with 4.93% increase in OI
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Article Listing News
Brawn Biotech informs about closure of trading window
In terms of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, Brawn Biotech has informed that the Trading Window for Designated Persons and their immediate relatives of the Company to deal in the securities of the Company shall remain closed with effect from 01 April 2026 till 48 hours after the declaration of Audited financial results for the quarter and financial year ended 31st March 2026. During the closure of the Trading Window, insiders have been advised not to deal in securities of the Company. The date of the Board meeting at which the said results will be considered and declared will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
Ashoka Metcast - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 18.54 | 0.00 | 0.00 | 32.62 | 17.98 | 81.42 | 32.62 | 17.98 | 81.42 |
| Other Income | 5.56 | 2.38 | 133.61 | 11.03 | 30.00 | -63.23 | 11.03 | 30.00 | -63.23 |
| PBIDT | 4.30 | 0.83 | 418.07 | 9.54 | 27.70 | -65.56 | 9.54 | 27.70 | -65.56 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 4.30 | 0.83 | 418.07 | 9.54 | 27.70 | -65.56 | 9.54 | 27.70 | -65.56 |
| Depreciation | 2.56 | 0.49 | 422.45 | 2.82 | 0.69 | 308.70 | 2.82 | 0.69 | 308.70 |
| PBT | 1.74 | 0.34 | 411.76 | 6.72 | 27.01 | -75.12 | 6.72 | 27.01 | -75.12 |
| TAX | 1.69 | -0.23 | -834.78 | 1.69 | 3.11 | -45.66 | 1.69 | 3.11 | -45.66 |
| Deferred Tax | -0.06 | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| PAT | 0.05 | 0.57 | -91.23 | 5.03 | 23.90 | -78.95 | 5.03 | 23.90 | -78.95 |
| Equity | 249.96 | 249.96 | 0.00 | 249.96 | 249.96 | 0.00 | 249.96 | 249.96 | 0.00 |
| PBIDTM(%) | 23.19 | 0.00 | 0.00 | 29.25 | 154.06 | -81.02 | 29.25 | 154.06 | -81.02 |
Gautam Exim informs about amendments to memorandum & articles of association
Arman Holdings informs about disclosures
Gautam Exim informs about appointment of secretarial auditor
No Records Found
Frequently Asked Questions
The current share price of Brawn Biotech Ltd. is ₹20.80 as of 2026-05-04.
The market capitalisation of Brawn Biotech Ltd. is ₹6.24 as of 2026-04-30.
The 1-year return of Brawn Biotech Ltd. is 3.56% as of 2025-04-30.
The P/E ratio of Brawn Biotech Ltd. is 0.00 as of 2026-05-04.
The 52-week high and low of Brawn Biotech Ltd. are ₹24.37 and ₹15.70, respectively, as of 2026-05-04.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
